I. INTRODUCTION {#acm20145-sec-0001}
===============

Radiation therapy has an increasingly important role in the medical field, particularly in the treatment of malignant diseases, such as cancer. Worldwide, about 40% of cancer patients require radiation treatment, either curative or palliative.[^1^](#acm20145-bib-0001){ref-type="ref"}, [^2^](#acm20145-bib-0002){ref-type="ref"} In this regard, radiation therapy is the only application of radiation in which very high radiation doses are deliberately delivered to a human body. However, maximum control on radiation dose to the target area of an individual (with minimum effects to the normal tissues) depends on various factors, particularly the accuracy in delivering the intended or prescribed dose. Severe toxicities or even fatal consequences can emerge from a slight variation from prescribed dose and can lead to an accidental consequences.[^3^](#acm20145-bib-0003){ref-type="ref"}, [^4^](#acm20145-bib-0004){ref-type="ref"} To prevent such unwanted events, a recommendation of at least $\pm 5\%$ accuracy or prescription at the 95% confidence level in the delivery of absorbed dose to the target volume of the treatment tumor has been suggested.[^5^](#acm20145-bib-0005){ref-type="ref"}, [^6^](#acm20145-bib-0006){ref-type="ref"}, [^7^](#acm20145-bib-0007){ref-type="ref"}, [^8^](#acm20145-bib-0008){ref-type="ref"}, [^9^](#acm20145-bib-0009){ref-type="ref"} These recommendations in clinical dosimetry are achieved gradually by assessing clinical data. However, radiotherapy is a multistep process and uncertainties in each step accumulate and affect the final dose delivered to the patients. These recommendations of accuracy level are for the final dose delivered to the patients. Besides these recommendations, Brahme[^(10)^](#acm20145-bib-0010){ref-type="ref"} and Mijnheer et al.[^(11)^](#acm20145-bib-0011){ref-type="ref"} have proposed a tolerance value of accuracy in dose delivery of $\pm 3.5\%$ and $\pm 3\%$, respectively, at one standard deviation (SD) level and by considering limiting uncertainties for acceptable increase in normal tissue complication risk.[^(5)^](#acm20145-bib-0005){ref-type="ref"} ICRU Report 24 also states the recommended uncertainty in the delivered dose to a phantom at 2.5% (optimal model) and 5% (minimal or "lowest acceptable" model).[^(7)^](#acm20145-bib-0007){ref-type="ref"}

In radiation therapy, the outcome of the treatment greatly depends on accuracy of the dose delivery to the patients, which in turn depends on target area localization, radiation dosimetry, and treatment planning and patient positioning. Among these factors, radiation dosimetry has a vital role in accurate dose delivery to the target area of the patients. However, published data[^4^](#acm20145-bib-0004){ref-type="ref"}, [^5^](#acm20145-bib-0005){ref-type="ref"}, [^8^](#acm20145-bib-0008){ref-type="ref"} have showed that many radiotherapy units have not been used properly because of inadequate dosimetry audits and lack of proper error analysis. Literature has showed that a total of 2,500,000 patients are yearly treated by around 6,000 to 7,000 teletherapy (i.e., Co‐60 and megavolts X‐ray) units. Of these patients, more than 10% are either overexposed or underexposed due to lack of proper equipment, personnel skill or training.[^(12)^](#acm20145-bib-0012){ref-type="ref"} In order to circumvent these problems and achieve the required level of accuracy (as stated earlier) and maintain consistency, a continued and comprehensive quality assurance (QA) of each step of radiotherapy is essential according the international guidelines.[^13^](#acm20145-bib-0013){ref-type="ref"}, [^14^](#acm20145-bib-0014){ref-type="ref"}, [^15^](#acm20145-bib-0015){ref-type="ref"} However, an independent external quality audit along with the local QA program is also recognized as a part of an effective method of checking the quality and accuracy in radiation dose delivery to the patients.[^(8)^](#acm20145-bib-0008){ref-type="ref"} In addition, this also establishes greater confidence in dose delivery among the local radiotherapy community. Due to the importance of the subject, the local and international regulatory organizations also emphasized the independent external quality audits. These organizations compelled the individual radiotherapy hospitals through their regulations to perform the audit on regular basis. The dosimetry audits and errors traceability of relevant clinics may be achieved either by postal measurements (i.e., by mailed‐in dosimeters), on‐site dosimetry visits using ionization chambers,[^(5)^](#acm20145-bib-0005){ref-type="ref"} or a mixture of both. Even though the on‐site dosimetry visits are troublesome because of traveling of personnel, equipment, and financial constraints, yet it is the most efficient and important method, as the dosimetry data and techniques are reviewed objectively. Furthermore, all the interfering parameters can be easily traced out on the spot and, as a result, the remedial actions can be immediately discussed with the local medical physicist at the radiotherapy hospital.[^(16)^](#acm20145-bib-0016){ref-type="ref"} For this task, the best suited organization may be either Primary Standards Dosimetry Laboratories (PSDLs) or Secondary Standards Dosimetry Laboratories (SSDLs) of the country, in addition to provided calibrated dosimetry systems at the relevant radiotherapy hospitals.[^(17)^](#acm20145-bib-0017){ref-type="ref"} As these laboratories have the standard/calibrated radiation dosimetry systems/sources and generally have trained/skilled manpower. For postal measurements and on‐site dosimetry visits to radiotherapy hospitals, the uncertainties should not be out of the range $\pm 5\%$ and $\pm 3\%$, respectively.[^9^](#acm20145-bib-0009){ref-type="ref"}, [^18^](#acm20145-bib-0018){ref-type="ref"}, [^19^](#acm20145-bib-0019){ref-type="ref"}, [^20^](#acm20145-bib-0020){ref-type="ref"}

In view of the above‐mentioned factors, an external dosimetry quality audit program has been designed at national level by the national SSDL through on‐site dosimetry visits to radiotherapy hospitals, starting in 1989. Since then, yearly, radiation beam output of teletherapy machines installed at different radiotherapy hospitals of Pakistan has been carried out. This study summarized and analyzed the results of these countrywide on‐site dosimetry visits to the radiotherapy centers. The study is also designed to discuss the possible sources of errors and provide suggestions to reduce these errors.

II. MATERIALS AND METHODS {#acm20145-sec-0002}
=========================

A series of dosimetry quality audits based on‐site visit with a reference dosimetry system, were performed for teletherapy units installed in different radiotherapy centers nation‐wide. According to the recommendations for on‐site dosimetry quality audit procedures, an external dosimetry system should be used for the audit. The dosimetry system (used for the on‐site dosimetry quality audits) consisted of a Farmer‐type cylindrical ionization chamber model NE2571 (Nuclear Enterprises America, Fairfield, NJ) with active volume of 0.69 cm^3^)[^(21)^](#acm20145-bib-0021){ref-type="ref"} connected to an electrometer (Farmer‐type dosimeter NE2570).[^(22)^](#acm20145-bib-0022){ref-type="ref"} The dosimetry system was attached to an IAEA stationary water phantom of size $30\,\text{cm} \times 30\,\text{cm} \times 30\,\text{cm}$. The dosimetry system was calibrated in a Co‐60 radiation beam at Secondary Standard Dosimetry Laboratory (SSDL) at

PINSTECH, Pakistan, following IAEA TRS‐398 protocol. The calibration (both in terms of air kerma and absorbed dose to water) was performed against a dosimetry system (calibrated both in terms of air kerma and the absorbed dose to water against the primary standard of the IAEA dosimetry laboratory, Vienna, Austria) consisting of an ionization chamber (type NE2561/NPL, serial no. 200) connected to an electrometer (type 2560, serial no. 173).[^(11)^](#acm20145-bib-0011){ref-type="ref"} Apart from the above dosimetry system and phantom, three barometers (Sr. No. B823, 86947, and 95882) and two thermometers (2100 Tele, Sr. No. 662, and glass thermometer, Sr. 57/15) were also used in order to make pressure and temperature corrections to the ionization chamber readings. Both the barometer and thermometer were calibrated from National Physical Standard Laboratory (NPSL), Islamabad, which is a subdivision of Pakistan Council of Scientific and Industrial Research (PCSIR).

All measurements were performed following the reference conditions of IAEA TRS‐277 and IAEA TRS‐398 dosimetry protocol (i.e., TRS‐277 was followed before the implementation of TRS‐398).[^23^](#acm20145-bib-0023){ref-type="ref"}, [^24^](#acm20145-bib-0024){ref-type="ref"} By following TRS‐277, the chamber was aligned in air at the reference depth from the source with buildup cap for a field size of $10\,\text{cm} \times 10\,\text{cm}$. To follow TRS‐398, the chamber was kept in PMMA sleeve (3.45 mm) and was then aligned in water phantom at the depth of 5 cm from the isocenter with buildup cap for a field size of $10\,\text{cm} \times 10\,\text{cm}$.[^25^](#acm20145-bib-0025){ref-type="ref"}, [^26^](#acm20145-bib-0026){ref-type="ref"} After taking the measurements, the physicists of the visited center were asked to carry out their dosimetry measurements by using their local dosimetry systems and setups (used for their routine dosimetry) at 5 cm depth from the isocenter for a field size of $10\,\text{cm} \times 10\,\text{cm}$. After getting their results, % deviation $(\%\,\Delta)$ between the "true" dose value (measured with the reference visiting dosimetry system), $D_{T}$, and the requested local dose determination (measured contextually with the local dosimetry system), $D_{L}$, was determined according to the following formula:[^(19)^](#acm20145-bib-0019){ref-type="ref"} $$\%\Delta = \frac{D_{L} - D_{T}}{D_{T}} \times 100$$The analyses of the results were performed with respect to the uncertainty limits of $\pm 2.5\%$ (ICRU "optimal model"),[^(7)^](#acm20145-bib-0007){ref-type="ref"} $\pm 3.0\%$ (IAEA on‐site dosimetry visits limit),[^9^](#acm20145-bib-0009){ref-type="ref"}, [^18^](#acm20145-bib-0018){ref-type="ref"}, [^27^](#acm20145-bib-0027){ref-type="ref"} and $\pm 5.0\%$ (ICRU minimal or "lowest acceptable" model).[^(7)^](#acm20145-bib-0007){ref-type="ref"}

III. RESULTS AND DISCUSSION {#acm20145-sec-0003}
===========================

A total of 181 dosimetry quality audits of teletherapy units (i.e., 102 of Co‐60 and 79 of linear accelerators), installed at 22 different clinics (details are given in [Table 1](#acm20145-tbl-0001){ref-type="table-wrap"}), were performed from 1989 to 2015, as shown in [Fig. 1](#acm20145-fig-0001){ref-type="fig"}. During the audit, the $\%\Delta$ between the users stated/measured dose output and the measured dose output (i.e., in the result of on‐site dosimetry visits) was determined. The maximum, minimum, and mean of $\%\Delta$ for all 181 dosimetry quality audits are $\pm 26.03\%$, $\pm 0.03\%$, and $\pm 2.08\%$ respectively with standard deviation of $\pm 3.3$. Out of 22 radiotherapy hospitals, six (27.3%) and one (4.5%) have a mean $\%\Delta$ greater than the acceptable limit of $\pm 2.5\%$ or $\pm 3\%$ and $\pm 5\%$, respectively, for both Co‐60 units and linear accelerators (see [Tables 2 and 3](#acm20145-tbl-0003){ref-type="table-wrap"}). For Co‐60 teletherapy units, a total of 102 audits were conducted for a total of 18 clinics. The $\%\Delta$ as function of year is plotted in [Fig. 2](#acm20145-fig-0002){ref-type="fig"}, and also summarized in [Table 2](#acm20145-tbl-0002){ref-type="table-wrap"}. Out of these 102 audits for Co‐60 units, 24.5%, 19.6%, and 6.9% are out of acceptable limits of $\pm 2.5\%$, $\pm 3.0\%$, and $\pm 5.0\%$, respectively, as shown in [Fig. 2](#acm20145-fig-0002){ref-type="fig"}. For linear accelerators, a total 79 audits were conducted for total of nine radiotherapy hospitals ([Table 1](#acm20145-tbl-0001){ref-type="table-wrap"}) and $\%\Delta$ as function of year is plotted in [Figs. 3](#acm20145-fig-0003){ref-type="fig"} and [4](#acm20145-fig-0004){ref-type="fig"} and also summarized in [Table 3](#acm20145-tbl-0003){ref-type="table-wrap"}. Out of 79 on‐site dosimetry audits, 15.2%, 11.4%, and 1.3% were out of acceptable limits of $\pm 2.5\%$, $\pm 3.0\%$, and $\pm 5.0\%$, respectively, as shown in [Figs. 3](#acm20145-fig-0003){ref-type="fig"} and [4](#acm20145-fig-0004){ref-type="fig"}. Out of all 181 audits, a larger $\%\Delta$ $( > 15\%)$ has also been observed for four audits (i.e., 26.03%, 25.08%, 18.3%, and 17.1%). These cases were thoroughly assessed and reasons were explored and conveyed to the users to minimize the errors. However, some common reasons are discussed here for the guidance of the readers. In most of these cases, correction of air density (pressure and temperature correction factor) might be the great cause because most of the radiotherapy hospitals used uncalibrated barometers and thermometers. According to TRS‐398 dosimetry protocol, thermometers and pressure gauges should be properly calibrated from a relevant calibration laboratory. Secondly, the problems were related to mechanical instability of the machines. These include isocentric deviation, difference between mechanical and optical SSD indicator and digital and mechanical display of the gantry angle. The hospital physicists always preferred to use optical SSD indicator and digital display of the gantry angles and, due to the considerable deviation between the optical and mechanical SSD indicator and digital and mechanical display of the gantry angles, the uncertainty raised. In short, the problems were related to the alignment of dosimetry systems and correct positioning of the ionization chambers. In some cases, mistakes in the implementation of the dosimetry protocols were also found (i.e., in using the correction factors, $K_{\text{qqo}},K_{\text{pol}},K_{\text{sat}}$). However, it is worth mentioning here that the dosimetry systems of the audited radiotherapy hospitals are calibrated from the Secondary Standard Dosimetry Laboratory (SSDL), Pakistan, which is a part of IAEA/WHO SSDL network.

###### 

Summary of the nation‐wide on‐site dosimetry visits of radiotherapy hospitals from 1989 to 2015

                *Radiotherapy Unit Audited*         *No. of Audits*                              
  ------- ----- ----------------------------- ----- ----------------- ------------- ------------ ----
  1\.     S1    √                             x     10                05            03           01
  2\.     S2    √                             x     04                01            01           01
  3\.     S3    √                             x     05                03            03           01
  4       S4    √                             x     03                ‐             ‐            ‐
  5\.     S5    √                             x     19                04            04           03
  6\.     S6    √                             x     03                02            01           01
  7\.     S7    √                             x     04                01            01           ‐
  8\.     S8    √                             x     04                01            01           ‐
  9\.     S9    √                             x     03                03            03           ‐
  10\.    S10   √                             x     02                ‐             ‐            ‐
  11\.    S11   √                             x     03                ‐             ‐            ‐
  12\.    S12   √                             x     02                ‐             ‐            ‐
  13\.    S13   √                             x     02                ‐             ‐            ‐
  14\.    S14   √                             √     11                07            07           01
  15\.    S15   √                             √     15                ‐             ‐            ‐
  16\.    S16   √                             √     22                04            02           ‐
  17\.    S17   √                             √     22                04            02           ‐
  18\.    S18   √                             √     19                02            01           ‐
  19\.    S19   x                             √     11                ‐             ‐            ‐
  20\.    S20   x                             √     08                ‐             ‐            ‐
  21\.    S21   x                             √     06                ‐             ‐            ‐
  22\.    S22   x                             √     02                ‐             ‐            ‐
  Total   18    09                            181   37 (20.44%)       29 (16.02%)   08 (4.42%)   

![Percentage deviation between the absorbed doses determined by the local physicists and the audit team of SSDL as function of number of audit at reference conditions from 1989 to 2015.](ACM2-17-145-g001){#acm20145-fig-0001}

###### 

Summary of the dosimetry quality audits of Co‐60 teletherapy units installed at 18 different sites (Sn) from 1989 to 2015

                         *% Deviation*                 
  ----- ----------- ---- --------------- ------ ------ -------
  S1    1989‐2013   10   2.11            1.91   0.1    6.1
  S2    1996‐2015   4    5.03            8.85   0.2    18.3
  S3    2004‐2014   5    3.16            1.81   0.8    5.3
  S4    1989‐2005   3    1.57            0.55   1.0    2.1
  S5    1989‐2012   19   4.7             8.24   0.3    26.03
  S6    1999‐2004   3    4.27            3.54   1.7    8.3
  S7    1996‐2008   4    1.3             1.39   0.2    3.1
  S8    1994‐2009   4    2.13            1.4    1.1    4.2
  S9    1994‐2013   3    4.0             0.36   3.6    4.3
  S10   1999‐2012   9    0.96            0.58   0.2    2.1
  S11   2013‐2014   2    0.85            0.78   0.3    1.4
  S12   2012‐2015   3    1.07            0.49   0.64   1.6
  S13   2013‐2014   2    0.35            0.07   0.3    0.4
  S14   2012‐2014   2    1.45            0.78   0.9    2.0
  S15   2004‐2009   2    0.55            0.21   0.4    0.7
  S16   2004‐2014   7    0.75            0.56   0.03   1.73
  S17   2006‐2013   8    1.94            1.11   0.7    4.0
  S18   1990‐2012   12   1.9             1.3    0.2    4.1

###### 

Summary of the dosimetry quality audits of linear accelerators installed at nine different sites ($S_{n}$) from 1989 to 2015

  *Site* $(S_{n})$   *Audits Period*   *Beam Energy (MV)*   *No. of Audits*   $\textit{Mean}\,( \pm )$   *SD*   $\textit{Minimum}\,( \pm )$   $\textit{Maximum}\,( \pm )$
  ------------------ ----------------- -------------------- ----------------- -------------------------- ------ ----------------------------- -----------------------------
  S14                2004‐2015         6                    5                 3.24                       2.16   0.8                           6.5
  15                 5                 3.45                 1.49              0.95                       4.8                                  
  S15                2008‐2014         6                    4                 0.62                       0.64   0.2                           1.57
  15                 4                 0.71                 0.65              0.16                       1.5                                  
  S16                1997‐2015         6                    7                 1.50                       0.67   0.7                           2.5
  15                 7                 1.76                 1.02              0.28                       3.2                                  
  S17                1989‐2013         6                    7                 0.79                       0.5    0.11                          1.32
  10/15              3                 1.6                  1.05              0.48                       2.56                                 
  S18                2002‐2010         6                    5                 2.01                       0.99   0.82                          3.4
  10/15              5                 1.98                 0.91              0.41                       2.7                                  
  S19                2007‐2015         6                    7                 1.08                       0.75   0.2                           2.2
  18                 4                 1.12                 0.45              0.73                       1.6                                  
  S20                1995‐2014         6                    4                 0.84                       0.62   0.1                           1.6
  15                 4                 0.98                 0.79              0.1                        2.01                                 
  S21                2006‐2010         6                    3                 0.74                       0.37   0.44                          1.15
  15                 3                 1.02                 0.83              0.3                        1.93                                 
  S22                2012‐2015         6                    2                 0.8                        0.57   0.4                           1.2

![Percentage deviation between the absorbed doses determined by the local physicists and the audit team of SSDL at reference conditions for Co‐60 teletherapy units from 1989 to 2015.](ACM2-17-145-g002){#acm20145-fig-0002}

![Percentage deviation between the absorbed doses determined by the local physicists and the audit team of SSDL at reference conditions for 6 MV photon beam emitted from linear accelerators from 1989 to 2015.](ACM2-17-145-g003){#acm20145-fig-0003}

![Percentage deviation between the absorbed doses determined by the local physicists and the audit team of SSDL at reference conditions for 10/15 and 18 MV photon beam emitted from linear accelerators from 1989 to 2015.](ACM2-17-145-g004){#acm20145-fig-0004}

The dosimetry quality audit is very important not only to check the accuracy of the radiation dose delivery to the patients, but also to reveal problems/issues related to the dosimetry measurements. These on‐site visits/audits have fruitful results in providing guidelines regarding implementation of the dosimetry protocols accurately. The highlighted issues/problems as a result of these audits included the unavailability of distilled water, properly calibrated thermometers, and pressure gauges and humidity meters at the radiotherapy hospitals. Moreover, the water was not kept at least 24 hours before the performing the dosimetry measurements at the measurement place for temperature stability. Most of the hospitals physicists were observed not using dosimetry systems and protocols properly. Moreover, it was also observed that physicists at the hospitals were normally not performing the reference check source measurements for their dosimetry systems (internal quality audit of dosimetry system). It was also noted that some of the hospitals followed different dosimetry protocols although their dosimetry systems were calibrated from SSDL, HPD, Pakistan, based on IAEA TRS‐398 dosimetry protocol. The considerable deviation in laser alignment systems with the isocenter of the source, locally fabricated/repaired treatment couch, and mechanical instability of the machines were also among the reasons for the uncertainties. Furthermore, some hospitals were also using Co‐60 units for radiotherapy treatments that had much lower dose rates than the IAEA recommended dose rate (i.e., 40 cGy/min for field size of $10\,\text{cm} \times 10\,\text{cm}$ at the depth of $D_{\text{max}}$) level.[^(27)^](#acm20145-bib-0027){ref-type="ref"}

V. CONCLUSIONS {#acm20145-sec-0004}
==============

The deviation from audited dose measurements arose due to the unavailability of calibrated thermometers, pressure gauges, and humidity meters at clinics. Attention was not given to properly following the recommendations/procedures of the relevant protocols about usage of water for measurements. The last main reason was related to issues regarding the quality assurance program of the teletherapy units for radiotherapy. Therefore, the importance of a proper ongoing quality assurance program and recommendations of the followed protocols is essential in maintaining the consistency and the uniformity of absorbed dose measurement for the precision of dose delivery to the patient.
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